Factors influencing the development of steroid-induced myopathies.
D000818:Animals; D001623:Betamethasone / Q000009:adverse effects*; D001835:Body Weight; D003907:Dexamethasone / Q000009:adverse effects*; D004285:Dogs; D006321:Heart / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects*; D066298:In Vitro Techniques; D008775:Methylprednisolone / Q000009:adverse effects*; D051379:Mice; D009132:Muscles / Q000187:drug effects; D009135:Muscular Diseases / Q000139:chemically induced*; D009929:Organ Size; D010248:Paramethasone / Q000009:adverse effects*; D005082:Physical Exertion; D011239:Prednisolone / Q000009:adverse effects*; D014221:Triamcinolone / Q000009:adverse effects*
D014221:Triamcinolone; D003907:Dexamethasone; D001623:Betamethasone; D011239:Prednisolone; D010248:Paramethasone; D006854:Hydrocortisone; D008775:Methylprednisolone